Brainstem BDNF neurons are downstream of GFRAL/GLP1R signalling
Growth differentiation factor 15, GDF15, and glucagon-like peptide-1 (GLP-1) analogues act through brainstem neurons that co-localise their receptors, GDNF-family receptor α-like (GFRAL) and GLP1R, to reduce food intake and body weight. However, their use as clinical treatments is partially hampered since both can also induce sickness-like behaviours, including aversion, that are mediated through a well-characterised pathway via the exterolateral parabrachial nucleus. Here, in mice, we describe a separate pathway downstream of GFRAL/GLP1R neurons that involves a distinct population of brain-derived neurotrophic factor (BDNF) cells in the medial nucleus of the tractus solitarius. Thus, BDNF<sup>mNTS</sup> neurons are required for the weight-reducing actions of both GDF15 and the GLP1RA, Exendin-4. Moreover, acute activation of BDNF<sup>mNTS</sup> neurons is sufficient to reduce food intake and drive fatty acid oxidation and might provide a route for longer-term weight loss.
Authors
- Mehdi Boutagouga Boudjadja (ORCID: https://orcid.org/0000-0001-8458-7758)
- Simon M. Luckman (ORCID: https://orcid.org/0000-0001-5318-5473)
- Rosemary Shoop (ORCID: https://orcid.org/0000-0002-3617-4358)
- Claire H. Feetham
- Amy A. Worth (ORCID: https://orcid.org/0000-0003-2573-7140)
- Paul J. Emmerson
- Tamer Coşkun (ORCID: https://orcid.org/0000-0002-2481-133X)
- Court Harding
- Sam Groom
- Giuseppe D’Agostino (ORCID: https://orcid.org/0000-0002-3502-4251)
- Valeria Collabolletta
Institutions
- Eli Lilly (United States) (US)
- University of Manchester (GB)
Publication Details
- Journal
- Nature Communications
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1038/s41467-024-54367-y
- Citations
- 7
- Primary Topic
- GDF15 and Related Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 3.29
Funders
- Eli Lilly and Company
- Directorate for Biological Sciences
- Medical Research Council
- Biotechnology and Biological Sciences Research Council